Optimizing Cognition Via Exercise and Nutrition
NCT05472831, Not applicable, Completed, University of Illinois at Urbana-Champaign
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Optimizing Cognition Via Exercise and Nutrition | ClinicalTrials.gov |
| NCT number | NCT05472831 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 28 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University of Illinois at Urbana-Champaign | ClinicalTrials.gov |
| Conditions | Cognitive Function 1, Social | ClinicalTrials.gov |
| Interventions | BAILAMOS dance program plus MIND diet, BAILAMOS dance program plus Health Education | ClinicalTrials.gov |
| First posted | 2022-07-25 | ClinicalTrials.gov |
| Last updated | 2025-08-19 | ClinicalTrials.gov |
Registered outcomes 14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Montreal Cognitive Assessment (MoCA) | Change in scores from baseline to post-intervention 6 months | MoCA version 8.1 Blind will be used to assess global cognition. The MoCA-BLIND assesses different cognitive domains such as attention and concentration, memory, language, conceptual thinking, calculations, and orientation. It contains the same items as the original MoCA except those requiring visual abilities have been removed as this is administered over the phone. Time to administer the MoCA- BLIND is approximately 5-10 minutes. The total possible score is 22 points; a score of 19 or above is considered normal. | ClinicalTrials.gov |
| Primary | WMS-R: Wechsler Memory Scale-Logical Memory I & II | Change in score from baseline to post-intervention 6 months | Logical Memory I \& II will be used to assess episodic memory. A brief story will be read to the participant who will then asked to retell it immediately (I) and after a 10- min delay filled with other activities (II). The score is the number of the 25 story units recalled immediately (I) and after the delay (II). | ClinicalTrials.gov |
| Primary | Stroop Neuropsychological Screening Test (Trennerry et al., 1989) | Change in score from baseline to post-intervention 6 months | Stroop Test will be used to assess executive function. In Stroop C, participants are shown a list of colors printed in conflicting color ink and are asked to read words (names of colors). The second part of this task is Stroop CW in which participants are shown a list of colors printed in conflicting color ink and are asked to say the color of the ink the word is printed. The scores are the number of words named correctly in 30 seconds and the number of colors named correctly in 30 seconds subtracting the number of errors. respectively. | ClinicalTrials.gov |
| Primary | Digit Span Test (Wechsler, 1987) | Change in score from baseline to post-intervention 6 months | Digit Span Forward \& Backward will be used to assess working memory. Digit strings of increasing length will be read, and the participant is asked to repeat each string forward (Digit Span Forward) or backward (Digit Span Backward). The score is the number of correctly retrieved strings in each part. | ClinicalTrials.gov |
| Primary | Word fluency Test (Welsh et al., 1994) | Change in score from baseline to post-intervention 6 months | Word Fluency will be used to assess executive function. The Word Fluency Test asks participants to name as many animals (part 1) or fruits and vegetables (part 2) as possible in 60 seconds. The score is the sum of the number of animals and the number of fruits and vegetables named. | ClinicalTrials.gov |
| Primary | Digit Ordering Test (Cooper at al., 1991) | Change in score from baseline to post-intervention 6 months | Digit ordering test will be used to assess working memory. For Digit Ordering, digit strings of increasing length will be read and the participant is asked to reorder the digits and say them in ascending order. The score is the number of correctly reordered strings. | ClinicalTrials.gov |
| Secondary | Minutes per day of light and moderate-to-vigorous physical activity via GT3x Actigraph Accelerometer | Change in minutes per day of light and moderate-to-vigorous physical activity from baseline to post-intervention 6 months | Device-assessed physical activity via GT3x Actigraph accelerometers will be used to assess minutes per day spent in light physical activity and moderate-to-vigorous physical activity. | ClinicalTrials.gov |
| Secondary | Godin-Shephard leisure-time physical activity questionnaire (GLTEQ) | Change in activity score from baseline to post-intervention 6 months | The GLTEQ is a 3-item questionnaire that assesses the number of times in the past week an individual participates in strenuous (eg, jogging), moderate (eg, brisk walking), and mild (eg, easy walking) exercise of more than 15 minutes in duration. Frequencies from the strenuous and moderate items are multiplied by 9 and 5 metabolic equivalents, respectively, and summed to calculate a moderate-to-vigorous activity score in accordance with the GLTEQ scoring protocol. | ClinicalTrials.gov |
| Secondary | MIND diet adherence | Change in MIND diet adherence from baseline to post-intervention 6 months | Block 2005 Food Frequency Questionnaire will be used to compute MIND diet scores. Frequency of consumption for food items was assigned a score of 0, 0.5, or 1, where scores ranged from 0 (lowest adherence) to 15 (highest adherence). | ClinicalTrials.gov |
| Secondary | National Institutes of Health (NIH) Toolbox: Perceived Stress Fixed Form Age 18+ v2.0 | Change in scores from baseline to post-intervention 6 months | NIH Tool box measure of perceived stress is a self-reported measure that assesses how unpredictable, uncontrollable, and overloaded respondents find their lives. 10 items are administered using a 5-point scale, with options ranging from "never" to "very often". Higher scores are indicative of higher perceived stress. | ClinicalTrials.gov |
| Secondary | National Institutes of Health (NIH) Toolbox General Life Satisfaction Fixed Form A Age 18+ v2.0 | Change in scores from baseline to post-intervention 6 months | NIH Tool box measure of general life satisfaction assesses global feelings and attitudes about one's life. 5 items are administered using a 5 and 7-point scale, ranging from "strongly disagree" to "strongly agree". Higher scores are indicative of higher general life satisfaction. | ClinicalTrials.gov |
| Secondary | National Institutes of Health (NIH) Tool Box: Sadness Fixed Form Age 18+ v2.0 | Change in scores from baseline to post-intervention 6 months | NIH Toolbox measure of depression/sadness assesses negative mood, negative views of self, and negative social cognition. 8 items are administered using a 5-point scale ranging from "never" to "always". Higher scores are indicative of more sadness. | ClinicalTrials.gov |
| Secondary | National Institues of Health (NIH) Toolbox Loneliness Fixed Form Age 18+ v2.0 | Change in scores from baseline to post-intervention 6 months | NIH Toolbox measure of loneliness assesses perceptions of loneliness using 5 items, responses from a 5-point scale ranging from "never" to "always". Higher scores are indicative of more loneliness. | ClinicalTrials.gov |
| Secondary | Spectroscopy-Based Veggie Meter® | Change in scores from baseline to post-intervention 6 months | The Veggie Meter (VM; Longevity Link Inc., Salt Lake City, UT, USA) is a commercially available device that uses reflection spectroscopy to measure the level of carotenoid pigments in a person's skin by scanning the tip of the finger. Scores range from 0-800. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|---|---|---|---|---|---|
| P30AG022849 | Midwest Roybal Center for Health Promotion and Translation | BHATT, TANVI; MARQUEZ, DAVID X | UNIVERSITY OF ILLINOIS AT CHICAGO | NATIONAL INSTITUTE ON AGING | 2003 to 2025 | NIH RePORTER |
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Primary outcome | ConductCognition |
| Short Story Recall | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)